← All trials
NCT07177157
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2025
- Primary completion
- Mar 31, 2027
- Completion date
- Mar 31, 2027
- First posted
- Sep 16, 2025
- Last posted
- Sep 16, 2025
- Enrollment
- 150
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- London Health Sciences CentreLead sponsor
- London Health Sciences CentreSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.